Smurfit WestRock PLC (SW) Stock News

The global eClinical Solutions market is projected to grow from USD 11.50 billion in 2025 to USD 42.55 billion by 2035, at a CAGR of 13.98%. Growth is driven by increased demand for efficient clinical trials, rising chronic disease prevalence, adoption of AI and cloud computing technologies, and decentralized trial models. Key players include Oracle, Veeva Systems, IQVIA, Medidata Solutions, and IBM Watson Health.

CSW Industrials reported record fiscal 2027 first quarter results with total revenue of $351 million (up 33%), adjusted EPS of $3.84 (up 35%), and adjusted EBITDA of $102 million (up 48%). The Contractor Solutions segment achieved 6% organic revenue growth for the second consecutive quarter. The company has invested $1 billion in five acquisitions since May 2025, including MARS Parts and Aspen Manufacturing, while maintaining a net leverage ratio of 2.37x within its target range.

The global AI in medical coding market is valued at USD 3 billion in 2025 and is expected to grow to USD 10.6 billion by 2035, expanding at a 13.5% CAGR. Key market players include 3M Company, Optum Inc., Nuance Communications Inc., Oracle Health, and others. The market growth is driven by increasing demand for automated code assignment, fraud detection, and compliance monitoring across healthcare providers and payers.

The global pharmaceutical surfactants market was valued at USD 4.5 billion in 2025 and is projected to reach USD 6.93 billion by 2035, growing at a CAGR of 4.42%. The market is driven by increasing demand for improved drug formulation, delivery systems, and expanding healthcare infrastructure. Non-ionic surfactants currently hold the largest market share, while Asia-Pacific is expected to be the fastest-growing region.

The global isobutanol market is projected to grow from USD 0.74 billion in 2025 to USD 1.89 billion by 2035, representing a 38% CAGR. Growth is driven by increasing demand for sustainable biofuel components, bio-based chemicals, and applications in coatings, solvents, and pharmaceuticals. Bio-based isobutanol is the fastest-growing segment, with Asia Pacific leading regional growth due to industrialization and green chemistry initiatives.

The global implantable cardiac fluorine-free resins market is valued at USD 1.52 billion in 2025 and is expected to grow to USD 4.26 billion by 2035 at a CAGR of 10.8%. Growth is driven by increasing cardiovascular disease prevalence, aging demographics, demand for biocompatible materials, and advancements in manufacturing technologies like additive manufacturing. Asia Pacific is projected to experience the fastest growth, while North America and Europe maintain steady expansion.

The global botulinum toxin in urology market is projected to grow from USD 1.1 billion in 2025 to USD 1.98 billion by 2035, at a CAGR of 6.08%. Growth is driven by increasing prevalence of urological disorders, aging populations, preference for minimally invasive treatments, and advancements in injection techniques. OnabotulinumtoxinA (Botox) leads the market, with overactive bladder being the largest application segment.

The global AI in drug repurposing market is projected to grow from USD 1.28 billion in 2025 to USD 10.56 billion by 2035, at a CAGR of 23.4%. The market is driven by the need to accelerate drug discovery, reduce development costs, and address growing instances of chronic and rare diseases. Key players include BostonGene Corporation, BenevolentAI, Innophore, Delta4.ai, BioXcel Therapeutics, and others. Software platforms dominate the market, with machine learning and natural language processing as leading technologies, while oncology represents the largest application segment.

The global high-pressure die casting market, valued at USD 62.8 billion in 2025, is expected to grow to USD 121.6 billion by 2035 at a 6.1% CAGR. Growth is driven by demand for lightweight components in electric vehicles and aerospace, technological innovations in vacuum-assisted casting, and expansion in automotive and electronics manufacturing. Key players include Nemak, Ryobi Limited, Dynacast International, Georg Fischer AG, and Endurance Technologies.

The global metal stamping market was valued at USD 261.4 billion in 2025 and is projected to reach USD 412.6 billion by 2035, growing at a CAGR of 4.6%. Growth is driven by increasing demand for lightweight precision components in automotive, EV production, consumer electronics, and aerospace industries. Key players include Magna International, Martinrea International, Gestamp Automoción, and others.

CSW Industrials declared a regular quarterly cash dividend of $0.30 per share payable August 14, 2026. The company reported robust fiscal 2026 fourth quarter results with record quarterly and full year performance, with the Contractor Solutions segment returning to positive organic growth.

The global intimate apparel market was valued at USD 97.3 billion in 2025 and is projected to reach USD 169.4 billion by 2035, growing at a CAGR of 5.7%. Growth is driven by increased female workforce participation, rising disposable incomes in Asia Pacific, and social media/influencer marketing. Asia Pacific leads in market share while Europe is expected to grow at the highest CAGR.

The global lithium-ion battery market is valued at USD 68.5 billion in 2025 and is expected to grow to USD 468.5 billion by 2035, driven by increasing adoption of energy storage systems, renewable energy infrastructure investments, and government policies supporting clean energy transitions. Key growth factors include rising electric vehicle demand, smart grid deployment, and declining battery costs.

The global green hydrogen market is projected to grow from USD 12.5 billion in 2025 to USD 188.9 billion by 2035, driven by demand from carbon-intensive industries seeking low-carbon alternatives and increasing adoption of hydrogen fuel cells in transportation. Major players include Siemens Energy, Nel ASA, ITM Power, and others, with recent developments including Nel ASA's USD 50 million PEM electrolyzer contract in Norway.

The global golf simulators market was valued at USD 2.4 billion in 2025 and is projected to reach USD 5.5 billion by 2035, growing at a CAGR of 8.6%. Growth is driven by increased accessibility, convenience, technological advancements, and rising demand for at-home entertainment. North America currently holds the largest market share, while Asia Pacific is expected to grow at the highest CAGR during the forecast period.

The global infant heart monitor market is projected to grow from USD 2.83 billion in 2025 to USD 7.93 billion by 2035, at a CAGR of 10.85%. Growth is driven by advancements in wearable medical technologies, rising adoption of remote monitoring, increased incidence of congenital heart defects, and expansion of healthcare infrastructure in emerging markets. North America leads the market while Asia-Pacific is expected to witness the fastest growth.

The global beadlets capsule market is projected to grow from USD 467.26 million in 2025 to USD 968.45 million by 2035, at a CAGR of 6.85%. Growth is driven by rising demand for advanced drug delivery systems in pharmaceuticals and nutraceuticals, increased consumer preference for wellness products, and advancements in microencapsulation technologies. Vitamin beadlets dominate by type, while pharmaceuticals lead by application, with Asia Pacific expected to show the fastest growth.

The global gauze bandage rolls market is valued at USD 1.96 billion in 2025 and is projected to reach USD 3.19 billion by 2035, growing at a CAGR of 4.97%. Growth is driven by rising surgical procedures, aging populations, chronic wound management, and technological advancements in antimicrobial and bioactive gauze products. Key market segments include cotton gauze (largest share), surgical wounds (dominant application), and hospitals (primary end-user), with Asia Pacific expected to show the fastest growth.

The global neonatal infant care market, valued at USD 3.06 billion in 2025, is expected to grow to USD 5.59 billion by 2035 at a CAGR of 6.21%. Growth is driven by rising preterm births, increasing neonatal complications, and technological innovations in monitoring and respiratory support systems. Hospitals and NICUs dominate the market, with incubators and ventilators as leading product categories.

The global human fibrinogen concentrate market, valued at USD 0.95 billion in 2025, is projected to grow at a 11.3% CAGR to reach USD 2.78 billion by 2035. Growth is driven by increasing bleeding disorders, surgical procedures, and demand for effective hemostatic therapies. Lyophilized forms dominate the market, with hospitals being the primary end-users. Asia Pacific is expected to experience the highest growth rate.

The global in silico clinical trials market, valued at USD 1.84 billion in 2025, is projected to grow to USD 8.94 billion by 2035 at a 15.2% CAGR. Growth is driven by high failure rates in traditional clinical trials, regulatory acceptance of computational evidence, advances in AI and digital twins, and ethical concerns about animal testing. North America dominates the market while Asia Pacific shows the fastest growth.

The global therapeutic apheresis market is projected to grow from USD 3.84 billion in 2025 to USD 8.94 billion by 2035, at a CAGR of 7.9%. Growth is driven by increased prevalence of chronic and autoimmune diseases, technological advancements in automated systems, and improved reimbursement policies. Key players include Terumo BCT, Fresenius Kabi, Haemonetics, and B. Braun Melsungen.

The global laboratory equipment services market is projected to grow from USD 28.94 billion in 2025 to USD 62.83 billion by 2035, at a CAGR of 8%. Growth is driven by increased R&D investments in life sciences, stricter regulatory compliance requirements, expansion of biopharma facilities, and adoption of IoT-enhanced predictive maintenance technologies. Repair and maintenance services represent the largest market segment, with North America dominating and Asia Pacific showing the fastest growth.

GlobalFoundries announced production readiness of its SLATE wafer-to-wafer bonding technology on the 9SW RF-SOI platform, enabling advanced 3D integration for compact cellular front-ends. The technology can reduce die size by up to 45% and is expected to ramp to volume production by H2 2027 at GF's Singapore facility. SLATE represents a significant advancement in RF integration for 5G and satellite communications applications.

The global onion powder market is valued at USD 1.34 billion in 2025 and is projected to reach USD 2.61 billion by 2035, growing at a CAGR of 6.2%. Growth is driven by increasing demand for convenient, shelf-stable ingredients in food processing, rising popularity of natural flavor additives, and expansion in ready-to-eat meals. North America currently dominates the market, while Asia Pacific shows the fastest growth due to high onion production and increasing urbanization.

The global decentralized clinical trials market is projected to grow from USD 9.9 billion in 2025 to USD 38.3 billion by 2035, at a CAGR of 14.5%. Growth is driven by digital health technologies, remote patient engagement, and ecosystem expansion involving CROs and platform vendors. Oncology represents the largest therapeutic segment at 45% market share, while pharmaceutical and biotech sponsors lead end-user adoption at 55% market share. North America currently dominates, while Asia-Pacific shows the fastest growth.

The United Steelworkers union strongly opposes the federal government's decision to abolish the Office of the Canadian Ombudsperson for Responsible Enterprise (CORE), arguing that while the office had limitations, eliminating it removes an important tool for holding Canadian companies accountable for human rights and labour rights abuses abroad. The USW calls on the government to reverse the decision and establish a genuinely independent ombudsperson with stronger investigative powers.

The global automated liquid handling systems market is valued at USD 2.7 billion in 2025 and is projected to reach USD 6.9 billion by 2035, growing at a CAGR of 9.8%. Growth is driven by increasing pharmaceutical R&D, clinical trials, technological advancements, and demand for automation in diagnostics and molecular testing. Key players include Eppendorf SE, PerkinElmer Inc., Thermo Fisher Scientific Inc., and QIAGEN NV.

The global ear health market is projected to grow from USD 10.12 billion in 2025 to USD 16.87 billion by 2035, at a CAGR of 5.7%. Growth is driven by rising hearing loss rates, aging populations, noise pollution exposure, and technological advancements in hearing aids and diagnostic devices. North America currently dominates the market, while Asia Pacific shows the fastest growth potential.

The global GLP-1 receptor agonist market, valued at USD 28.7 billion in 2025, is projected to grow to USD 95.3 billion by 2035 at a 12.1% CAGR. Growth is driven by rising type 2 diabetes and obesity cases, technological innovations including oral formulations, and expanded insurance coverage. North America leads the market while Asia Pacific shows the highest growth rate.